Linden Thomas Advisory Services, LLC BMRN BIOMARIN PHARMACEUTICAL INC

Ownership history in Linden Thomas Advisory Services, LLC  ·  8 quarters on record

AI Ownership Summary

Linden Thomas Advisory Services, LLC reported BIOMARIN PHARMACEUTICAL INC (BMRN) in 8 quarterly 13F filings from 2024 Q1 through 2026 Q2. Peak portfolio weight reached 0.25% in 2024 Q1. The latest visible filing shows BMRN at 0.06% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this BMRN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Linden Thomas Advisory Services, LLC's position in BIOMARIN PHARMACEUTICAL INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

BMRN was reported at 0.06% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.25% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Linden Thomas Advisory Services, LLC held BMRN — position size vs. price
% of Fund (quarterly)    BMRN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 3 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 12,277 -26 -0.2% 0.06% $702K 2026-07-16 $60.00
2026 Q1 REDUCED 31.3% +2.1% 12,303 -5,597 -31.3% 0.07% $695K 2026-04-10 $54.53
2024 Q1 ADDED 17,900 +17 +0.1% 0.25% $1.6M 2024-04-30 $80.76
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Linden Thomas Advisory Services, LLC and BMRN

These are the practical questions this page is built to answer before you even open the full history table.

How long has Linden Thomas Advisory Services, LLC reported owning BMRN?

Linden Thomas Advisory Services, LLC reported BMRN across 3 quarterly 13F filings, from 2024 Q1 through 2026 Q2.

What was the largest reported BMRN position in Linden Thomas Advisory Services, LLC's portfolio?

The largest reported portfolio weight for BMRN was 0.25% in 2024 Q1.

What is the latest reported BMRN position on this page?

The most recent filing on this page is 2026 Q2, when Linden Thomas Advisory Services, LLC reported 12,277 shares, equal to 0.06% of portfolio, with an estimated market value of $702K.

What does the chart on this BMRN ownership page compare?

The chart compares Linden Thomas Advisory Services, LLC's quarterly BMRN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Linden Thomas Advisory Services, LLC time their BMRN position?

Based on 13F filing dates vs. subsequent BMRN price moves, Linden Thomas Advisory Services, LLC correctly timed 1 out of 7 reported position changes (14%). The annualised alpha on BMRN relative to SPY over the holding period was -30.2%.

← Back to Linden Thomas Advisory Services, LLC Holdings